MARCO TATULLO1,*, LUISA LIMONGELLI2, ROSA MARIA MARANO3, ALESSANDRA VALLETTA4, ANGELA TEMPESTA2, SANDRO RENGO4
BIOCELL, Vol.46, No.8, pp. 1837-1842, 2022, DOI:10.32604/biocell.2022.020570
Abstract The scientific community is continuously working to translate the novel biomedical techniques into effective
medical treatments. CRISPR-Cas 9 system (Clustered Regularly Interspaced Short Palindromic Repeats-9), commonly
known as the “molecular scissor”, represents a recently developed biotechnology able to improve the quality and the
efficacy of traditional treatments, related to several human diseases, such as chronic diseases, neurodegenerative
pathologies and, interestingly, oral diseases. Of course, dental medicine has notably increased the use of
biotechnologies to ensure modern and conservative approaches: in this landscape, the use of CRISPR-Cas-9 system
may speed and personalize the traditional therapies, ensuring More >